Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Wenhao Cao, Hongjian Zhu, Li Wang, Lixin Zhang, Jun Yu |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
por: Luana Boumendil, et al.
Publicado: (2024)
por: Luana Boumendil, et al.
Publicado: (2024)
Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints
por: Matthias Kormaksson, et al.
Publicado: (2024)
por: Matthias Kormaksson, et al.
Publicado: (2024)
Use of win time for ordered composite endpoints in clinical trials
por: James F. Troendle, et al.
Publicado: (2024)
por: James F. Troendle, et al.
Publicado: (2024)
A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials
por: Yu Du, et al.
Publicado: (2024)
por: Yu Du, et al.
Publicado: (2024)
A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
por: Tianyu Zhan
Publicado: (2024)
por: Tianyu Zhan
Publicado: (2024)
Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
por: Xiaotian Chen, et al.
Publicado: (2025)
por: Xiaotian Chen, et al.
Publicado: (2025)
Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table
por: Edward L. Korn, et al.
Publicado: (2024)
por: Edward L. Korn, et al.
Publicado: (2024)
Improved mortality analysis in early‐phase dose‐ranging clinical trials for emergency medical diseases using Bayesian time‐to‐event models with active comparators
por: Xiaosong Shi, et al.
Publicado: (2024)
por: Xiaosong Shi, et al.
Publicado: (2024)
Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design
por: Yunfei Wang
Publicado: (2024)
por: Yunfei Wang
Publicado: (2024)
Group sequential designs for clinical trials when the maximum sample size is uncertain
por: Amin Yarahmadi, et al.
Publicado: (2024)
por: Amin Yarahmadi, et al.
Publicado: (2024)
Assurance methods for designing a clinical trial with a delayed treatment effect
por: James A. Salsbury, et al.
Publicado: (2024)
por: James A. Salsbury, et al.
Publicado: (2024)
A Bayesian nonparametric meta‐analysis model for estimating the reference interval
por: Wenhao Cao, et al.
Publicado: (2024)
por: Wenhao Cao, et al.
Publicado: (2024)
Correction to “Propensity score weighting for covariate adjustment in randomized clinical trials”
por: Shuxi Zeng, et al.
Publicado: (2024)
por: Shuxi Zeng, et al.
Publicado: (2024)
Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials
por: Jialu Fang, et al.
Publicado: (2024)
por: Jialu Fang, et al.
Publicado: (2024)
Correction to “Using principal stratification in analysis of clinical trials”
por: Ilya Lipkovich, et al.
Publicado: (2024)
por: Ilya Lipkovich, et al.
Publicado: (2024)
Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
por: Peiran Liu, et al.
Publicado: (2024)
por: Peiran Liu, et al.
Publicado: (2024)
Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
por: Jonathan C. Moyer, et al.
Publicado: (2024)
por: Jonathan C. Moyer, et al.
Publicado: (2024)
Bayesian Tensor Decomposition for Clustering Latent Symptom Profiles for Verbal Autopsy Data
por: Yu Zhu, et al.
Publicado: (2026)
por: Yu Zhu, et al.
Publicado: (2026)
Estimation and reduction of bias in self‐controlled case series with non‐rare event dependent outcomes and heterogeneous populations
por: Kenneth Menglin Lee, et al.
Publicado: (2024)
por: Kenneth Menglin Lee, et al.
Publicado: (2024)
Confidence distributions for treatment effects in clinical trials: Posteriors without priors
por: Ian C. Marschner
Publicado: (2024)
por: Ian C. Marschner
Publicado: (2024)
A sequential, multiple assignment, randomized trial design with a tailoring function
por: Holly Hartman, et al.
Publicado: (2024)
por: Holly Hartman, et al.
Publicado: (2024)
Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials
por: Xi Fang, et al.
Publicado: (2026)
por: Xi Fang, et al.
Publicado: (2026)
The Role of Congeniality in Multiple Imputation for Doubly Robust Causal Estimation
por: Lucy D'Agostino McGowan
Publicado: (2026)
por: Lucy D'Agostino McGowan
Publicado: (2026)
Group Response‐Adaptive Randomization With Delayed and Missing Responses
por: Guannan Zhai, et al.
Publicado: (2024)
por: Guannan Zhai, et al.
Publicado: (2024)
A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart
por: Stephen Schüürhuis, et al.
Publicado: (2024)
por: Stephen Schüürhuis, et al.
Publicado: (2024)
BHAFT: Bayesian heredity‐constrained accelerated failure time models for detecting gene‐environment interactions in survival analysis
por: Na Sun, et al.
Publicado: (2024)
por: Na Sun, et al.
Publicado: (2024)
Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi‐Arm Clinical Trials
por: Jiaqi Tong, et al.
Publicado: (2025)
por: Jiaqi Tong, et al.
Publicado: (2025)
Confidence intervals for odds ratio from multistage randomized phase II trials
por: Shiwei Cao, et al.
Publicado: (2024)
por: Shiwei Cao, et al.
Publicado: (2024)
Doubly Robust Estimation of Marginal Cumulative Incidence Curves for Competing Risk Analysis
por: Patrick van Hage, et al.
Publicado: (2025)
por: Patrick van Hage, et al.
Publicado: (2025)
Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial
por: Johannes Krisam, et al.
Publicado: (2024)
por: Johannes Krisam, et al.
Publicado: (2024)
An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation
por: Ariel Alonso Abad, et al.
Publicado: (2024)
por: Ariel Alonso Abad, et al.
Publicado: (2024)
Multiple imputation strategies for missing event times in a multi‐state model analysis
por: Elinor Curnow, et al.
Publicado: (2024)
por: Elinor Curnow, et al.
Publicado: (2024)
Multiply robust generalized estimating equations for cluster randomized trials with missing outcomes
por: Dustin J. Rabideau, et al.
Publicado: (2024)
por: Dustin J. Rabideau, et al.
Publicado: (2024)
Utilizing local likelihood in regression discontinuity design: Investigating the impact of antiretroviral therapy eligibility on retention in clinical HIV care in South Africa
por: Jaehyun Seo, et al.
Publicado: (2024)
por: Jaehyun Seo, et al.
Publicado: (2024)
Enhancing long‐term survival prediction with two short‐term events: Landmarking with a flexible varying coefficient model
por: Wen Li, et al.
Publicado: (2024)
por: Wen Li, et al.
Publicado: (2024)
τ$$ \tau $$‐Inflated beta regression model for censored recurrent events
por: Yizhuo Wang, et al.
Publicado: (2024)
por: Yizhuo Wang, et al.
Publicado: (2024)
Bayesian Longitudinal Network Regression With Application to Brain Connectome Genetics
por: Chenxi Li, et al.
Publicado: (2025)
por: Chenxi Li, et al.
Publicado: (2025)
Assessing Treatment Effects in Observational Data With Missing Confounders: A Comparative Study of Practical Doubly‐Robust and Traditional Missing Data Methods
por: Brian D. Williamson, et al.
Publicado: (2026)
por: Brian D. Williamson, et al.
Publicado: (2026)
Beyond the two‐trials rule
por: Leonhard Held
Publicado: (2024)
por: Leonhard Held
Publicado: (2024)
A Bayesian non‐stationary heteroskedastic time series model for multivariate critical care data
por: Zayd Omar, et al.
Publicado: (2024)
por: Zayd Omar, et al.
Publicado: (2024)
Ejemplares similares
-
Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
por: Luana Boumendil, et al.
Publicado: (2024) -
Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints
por: Matthias Kormaksson, et al.
Publicado: (2024) -
Use of win time for ordered composite endpoints in clinical trials
por: James F. Troendle, et al.
Publicado: (2024) -
A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials
por: Yu Du, et al.
Publicado: (2024) -
A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
por: Tianyu Zhan
Publicado: (2024)